Position in BBIO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$573,658
+$156,788 QoQ
Shares Held
7,725
+41.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PFG Investments, LLC holds $8,383,926 across 23 Biotechnology names. BBIO ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADMA |
Adma Biologics, Inc.
|
222,729 | $2,006,788 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,134 | $952,916 | |
| 3 | ARDX |
Ardelyx, Inc.
|
137,860 | $825,781 | |
| 4 | NGEN |
Nervgen Pharma Corp.
|
201,000 | $757,770 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,890 | $665,269 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
7,725 | $573,658 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
20,843 | $453,543 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,455 | $432,091 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $573,658 | 7,725 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $416,870 | 5,450 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $288,267 | 5,550 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $254,762 | 5,900 | Shares | Sole | 2025-07-18 | |
| No filing history on record for this holder in this stock. | ||||||